Form D · Biotechnology
Triphase Accelerator G.P. Corp
San Diego, CA · CIK 0001561259
Offering snapshot reported Oct 29, 2012 · SEC filing
- Reported sold
- $376 Offering amount: $376
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 15, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 29, 2012 | Initial | $376 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-186213
Common Stock
Source: Form D, filed Oct 29, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Grant Gibson | Executive |
| Raphael Hofstein | Director |
| Thomas Hudson | Director |
| Frank Stonebanks | Director, Executive |
| Ilse Treurnicht | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3210 Merryfield Row, Suite 5811
San Diego, CA, 92121
San Diego, CA, 92121